Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual parenteral artemisinin-based combination therapy for cerebral malaria in Nigerian children
PACTR202102893629864Not yet recruiting
- Sponsor
- Alao Michael & Co
- Start
- Jul 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial of artesunate and quinine in cerebral malaria (CM) and malaria (3 arms), sponsored by Alao Michael & Co. Primary endpoint: Effectiveness in terms of survival and full recovery. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
artesunatequinine
03
Conditions
cerebral malaria (CM)malaria
Beyond the preview
Go deeper on PACTR202102893629864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202102893629864.